Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email firstname.lastname@example.org.
Check back regularly for news, coverage, and announcements about MAVA.
Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $20 million term loan with with Zafgen, Inc.
AddThis, the Vienna-based developer of a popular social sharing and analytics platform, said on Thursday it has formed a new content media services group, and has also hired three new executives.
The Center for Innovative Technology announced today that its CIT GAP Funds closed an investment in Urgent.ly, a Northern Virginia-based startup offering a mobile on-demand platform that quickly and easily connects users with nearby and available roadside assistance.
The Center for Innovative Technology announced today that its CIT GAP Funds closed an investment in Riogin, a Charlottesville-based company that has solved many issues related to peptide therapeutics.
The Maryland Technology Development Corporation (TEDCO) announced today that nine finalists have been selected in the organization’s fourth annual ICE Awards.
Venture firms across the U.S. raised a collective $8.9 billion in the first three months of 2014, marking the industry's healthiest quarter in seven years, according to data released Monday by the National Venture Capital Association and Thomson Reuters.
The Herndon-based Center for Innovative Technology (CIT) said it has invested an unspecified amount in Neoantigenics, a Charlottesville-based biotech company developing a targeted treatment for cancer.
New Enterprise Associates (NEA), the Chevy Chase-based venture capital firm, has announced plans for the second installment of its design mentorship program, known as "In the Studio."
About 100 days ago, Alana Bly and Raavi Iqbal took a big risk. They quit their jobs to pursue a startup full-time. Luckily, it paid off.
The Center for Innovative Technology (CIT) announced today that its CIT GAP Funds' portfolio reached 100 companies with an investment in Neoantigenics, a University of Virginia spin-out and Charlottesville-based biotech company that is developing a targeted treatment for cancer.